BiologicalDrug

Vascular endothelial growth factor receptor 1 clinical trials

studies test it: 11
open now: 0
in phase 3: 1
first study started: 2007

How studies write it

Studies that test it under each name

Studies by the year they started

11 studies that test it; most in 2008 (5)

Studies that test vascular endothelial growth factor receptor 1, by start year
Year	Studies
2007	1
2008	5
2009	2
2010	1
2015	1
2018	1

By phase

A phase 1/2 study counts in both.

Phase 1: 8
Phase 2: 6
Phase 3: 1
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 2
Brain Neoplasms: 2
Head and Neck Neoplasms: 2
Pancreatic Neoplasms: 2
Macular Degeneration: 1
Esophageal Neoplasms: 1
Colorectal Neoplasms: 1

Who runs them

Industry 1 · Other 10

Tokyo University (3) · University of Pennsylvania (1) · Frederick Daniel Grant (1) · Siemens Molecular Imaging (1) · Osaka University (1) · Japanese Foundation for Cancer Research (1) · University of Utah (1) · Fukushima Medical University (1)

Often tested with

Tested in the same studies.

Vascular endothelial growth factor receptor 2 (5) · Ribociclib (1) · Paclitaxel (1) · Lymphocyte Antigen 6K (1) · Fluciclovine (1) · Gemcitabine (1)

Studies

Open first, then newest update. How each study uses vascular endothelial growth factor receptor 1 is read from its arms, and is right about nine times in ten.

Vascular endothelial growth factor receptor 1 clinical trials

How studies write it

Name

Other names

Combined with it in one product